IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 334 filers reported holding IONIS PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 0.71 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $639,000 | -22.0% | 14,204 | -1.9% | 0.01% | -50.0% |
| Q4 2020 | $819,000 | +26.0% | 14,479 | +5.7% | 0.01% | +9.1% |
| Q3 2020 | $650,000 | -18.0% | 13,694 | +1.9% | 0.01% | -26.7% |
| Q2 2020 | $793,000 | +39.6% | 13,445 | +11.9% | 0.02% | +7.1% |
| Q1 2020 | $568,000 | -18.7% | 12,010 | +3.8% | 0.01% | -12.5% |
| Q4 2019 | $699,000 | +5.7% | 11,565 | +4.8% | 0.02% | 0.0% |
| Q3 2019 | $661,000 | -0.8% | 11,038 | +6.5% | 0.02% | -5.9% |
| Q2 2019 | $666,000 | – | 10,365 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tweedy, Browne Co LLC | 3,510,173 | $159,221,447 | 8.52% |
| Bellevue Group AG | 9,233,700 | $418,840,632 | 6.75% |
| Deep Track Capital, LP | 2,834,069 | $128,553,370 | 4.96% |
| BVF INC/IL | 4,004,613 | $181,649,246 | 4.90% |
| Sicart Associates LLC | 203,132 | $9,214,068 | 3.61% |
| Camber Capital Management LP | 2,250,000 | $102,060 | 3.36% |
| Privium Fund Management B.V. | 228,493 | $10,364,443 | 3.08% |
| Orbimed Advisors | 2,169,500 | $98,408,520 | 2.09% |
| SECTOR GAMMA AS | 165,616 | $7,512,342 | 1.92% |
| TANAKA CAPITAL MANAGEMENT INC | 14,612 | $663 | 1.89% |